• CSR Summary
• NCT Number Not Available
• Primary Citation Not Yet Available
• Data Specification

Approved Data Requests Associated with this Trial

• 2025-0836 : rEVealIng Drug Effects when applyiNg psychomeTrics In schizophreniA triaLs (EVIDENTIAL)
• 2025-0740 : Trajectories of Relapse and Predictors of Functioning in Antipsychotic Clinical Trials
• 2025-0568 : Antipsychotic-Induced Negative Symptoms in Individuals with Schizophrenia: An Individual Participant Data Meta-Analysis of RCTs
• 2025-0352 : ALL-EMBRACED: clinicAL triaLs web-sErvice to Modify eligiBility cRiteria and pre-screening viA artifiCial intElligence methoDs
• 2024-0608 : Understanding treatment effects and symptom dynamics in schizophrenia using network analysis
• 2024-0436 : EXploring SEx-related Mechanisms of Psoriatic Arthritis response to advanced therapies (EXSEMP): Individual participant data (IPD) meta-analysis
• 2024-0008 : Sex differences in antipsychotic efficacy and side-effects in adults with acute exacerbations of schizophrenia: an individual-participant network meta-analysis
• 2022-4992 : Temporal trajectories of side-effects associated with antipsychotic treatment: An individual participant data meta-analysis
• 2021-4754 : Harnessing clinical trial data to inform real-world clinical decision making in the treatment of schizophrenia
• 2021-4575 : A Novel Method to Summarize Safety in Clinical Trials Using Pharmacological Class-Related Risks in FAERS
• 2019-3978 : Safety of Risperidone and Paliperdone in schizophrenia and bipolar disorder diagnosed patients - a systematic review and meta-analysis
• 2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.
• 2019-3941 : Factors moderating estimates of antipsychotic efficacy in schizophrenia
• 2019-3827 : Prediction of outcome and adverse events in antipsychotic treatment
• 2017-1846 : Discontinuation symptoms in antipsychotics: Individual patient level analyses of randomized controlled trials
• 2017-1676 : Placebo Effects in Schizophrenia
• 2016-0880 : Incidence of death and other SAEs related to second generation antipsychotic or placebo treatment in RCTs - a systematic review and meta-analysis